You are here

  • Home
  • Archive
  • Volume 3, Issue 4
  • Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study

Article metrics

Article menu

Download PDFPDF

XML
Diabetes and endocrinology
Research
Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 201855476
Feb 201832277
Mar 2018746616
Apr 2018473117
May 201862448
Jun 201857338
Jul 2018301812
Aug 2018272315
Sep 2018351712
Oct 2018322617
Nov 2018282616
Dec 2018141410
Jan 2019242211
Feb 2019242415
Mar 2019211713
Apr 2019251711
May 2019261015
Jun 2019231515
Jul 201919137
Aug 2019251716
Oct 201922187
Nov 201915139
Dec 2019141410
Jan 202016156
Feb 2020272110
Mar 2020141011
May 2020881
Jun 2020537
Jul 202015114
Aug 20201196
Sep 2020221720
Oct 202039298
Nov 2020271611
Dec 202017146
Jan 2021241311
Feb 20211174
Mar 202116146
Apr 202121153
May 202115155
Jun 202116164
Jul 202115158
Aug 202117166
Sep 202110106
Oct 2021161615
Nov 2021201523
Dec 202118161
Jan 2022191310
Feb 202222184
Mar 202233275
Apr 202221194
May 2022292711
Jun 2022504410
Jul 202223137
Aug 202210105
Sep 2022231911
Oct 2022937713
Nov 202228257
Dec 202219126
Jan 2023202015
Feb 20231552
Mar 202325176
Apr 20231496
May 20232186
Jun 202318124
Jul 2023667
Aug 2023774
Sep 2023161111
Oct 202323224
Nov 20236613
Dec 202364216
Jan 202420186
Feb 202495955
Mar 2024595446
Apr 2024373725
Total19471525714